FDA Inspection
Agon Pharma Private LtdAgon Pharma Private Ltd – FDA Inspection, Jun 13, 2019
Record Details
This FDA Inspection record concerns Agon Pharma Private Ltd, with an inspection on June 13, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · 37d382e2-17fc-4e30-8c99-66c513aedea2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1094298
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.105(a)Identification of containers, lines, equipment
- 21 CFR 211.80(d)Status of Each Lot Identified
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Agon Pharma Private Ltd
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Agon Pharma Private Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.